首页> 外文期刊>Clinical and experimental rheumatology >The two faces of the inflammasome adaptor ASC in epithelial skin carcinogenesis
【24h】

The two faces of the inflammasome adaptor ASC in epithelial skin carcinogenesis

机译:炎性体衔接子ASC在皮肤上皮癌变中的两个面

获取原文
获取外文期刊封面目录资料

摘要

The development of tumours is a multistep process during which cells acquire the capability to sustain proliferation, evade growth suppressors and/or resist cell death. One factor, which is increasingly recognised to influence tumour progression, is the inflammatory environment of the tumour. The responsible molecular mechanisms and signalling pathways are only beginning to emerge. One major pathway able to induce potent inflammation is the activation of the inflammasome and the subsequent secretion of the pro-inflammatory cytokines IL-1?2 and IL-18. Both these cytokines have been implicated in tumour-genesis/progression. However, evidence for the role of inflammasomes in this process is still scarce and mainly derived from murine colitis associated tumour models. In this short review we discuss current knowledge on the role of inflammasomes in epithelial cancer of the gut and skin with a special focus on the complex role of the inflammasome adaptor ASC in epithelial skin carcinogenesis.
机译:肿瘤的发展是一个多步过程,在此过程中,细胞获得了维持增殖,逃避生长抑制剂和/或抵抗细胞死亡的能力。人们越来越认识到影响肿瘤进展的因素之一是肿瘤的炎症环境。负责任的分子机制和信号传导途径才刚刚开始出现。能够诱导有效炎症的一种主要途径是炎性体的激活以及促炎性细胞因子IL-1?2和IL-18的随后分泌。这两种细胞因子均与肿瘤发生/进展有关。然而,炎性小体在该过程中的作用的证据仍然很少,并且主要来源于鼠结肠炎相关的肿瘤模型。在这篇简短的评论中,我们讨论了炎性小体在肠道和皮肤上皮癌中的作用的当前知识,并特别关注了炎性小体衔接子ASC在上皮性皮肤癌变中的复杂作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号